Table 2.
Marker | FC | P-value | FDRq | Description& |
---|---|---|---|---|
Creatine Kinase MB*#$ | 6.52 | <0.0001 | <0.0001 | cytoplasmic enzyme involved in energy homeostasis – cardiac isoenzyme |
Tissue-type Plasminogen Activator*% | 1.64 | <0.0001 | 0.0002 | serine protease involved in fibrinolysis, tumor angiogenesis, and myogenesis [29] |
Myoglobin*# | 2.23 | 0.0001 | 0.006 | Iron-binding muscle protein |
Epidermal Growth Factor*# | 2.33 | 0.0004 | 0.01 | Potent mitogenic factor, important role in the growth, proliferation and differentiation of numerous cell types. |
Chemokine (C-C motif) ligand 2 | 1.48 | 0.0004 | 0.01 | Recruits monocytes to sites of injury and infection. |
CD40 Ligand*# | 1.89 | 0.001 | 0.03 | Expressed on the surface of T cells, regulates B cell function by engaging CD40 |
Vitronectin*# | 1.28 | 0.001 | 0.03 | Cell adhesion factor. Stabilizes PAI-1*. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway. |
Descriptions taken from the Human Protein Reference Data Base, and NCBI gene reference
Markers with false discovery rate <5%
Log transformed for analysis.
Group estimates and statistical test from the GLM model adjusted for gender
Group estimates and statistical test from the GLM model adjusted for age
FC = fold change (positive FSH > control; negative control > FSH); FDR = false discovery rate